CRYPTOSPORIDIUM PARVUM - ANVISA Registration 80254180294

Access comprehensive regulatory information for CRYPTOSPORIDIUM PARVUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180294 and manufactured by REMEL EUROPE LIMITED. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, HYSEN BIOTECH.LNC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.